KR900007946B1 - Novel microorganism for producing of glutamic acid - Google Patents

Novel microorganism for producing of glutamic acid Download PDF

Info

Publication number
KR900007946B1
KR900007946B1 KR1019880016541A KR880016541A KR900007946B1 KR 900007946 B1 KR900007946 B1 KR 900007946B1 KR 1019880016541 A KR1019880016541 A KR 1019880016541A KR 880016541 A KR880016541 A KR 880016541A KR 900007946 B1 KR900007946 B1 KR 900007946B1
Authority
KR
South Korea
Prior art keywords
glutamic acid
medium
producing
culture
kfcc
Prior art date
Application number
KR1019880016541A
Other languages
Korean (ko)
Other versions
KR900009964A (en
Inventor
현형환
이윤기
정성오
심재익
오윤석
Original Assignee
제일제당 주식회사
손영희
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 제일제당 주식회사, 손영희 filed Critical 제일제당 주식회사
Priority to KR1019880016541A priority Critical patent/KR900007946B1/en
Publication of KR900009964A publication Critical patent/KR900009964A/en
Application granted granted Critical
Publication of KR900007946B1 publication Critical patent/KR900007946B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor

Abstract

Glutamic acid producing Brevibacterium lactofermentum KFCC 10659 (I) having osmo-tolerance and can not use glutamic acid as carbon-source or nitrogen-source is prepd. by treating the original strain Brevibacterium lactofermentum ATCC 13869 with UV or NTG. Prodn. of glutamic acid comprises culturing (I) in a medium cong. waste syrup, glucose, starch hydrolyte, etc, and obtaining glutamic acid from the culture broth.

Description

글루타민산을 생산하는 미생물 및 이를 이용한 글루타민산의 제조방법Microorganisms Producing Glutamic Acid and Methods for Preparing Glutamic Acid Using the Same

본 발명은 글루타민산을 생산하는 미생물 및 이를 이용한 글루타민산의 제조방법에 관한 것으로, 좀더 구체적으로는 브레비박테리움 락토퍼멘텀 ATCC 13869의 변이주로서 삼투압 내성을 가짐과 동시에 글루타민산을 탄소원 및 질소원으로 자화할 수 없는 특징이 있어 폐당밀이 주성분인 배지에서도 글루타민산을 고수율, 고농도로 생산할 수 있는 미생물에 관한 것이다.The present invention relates to a microorganism producing glutamic acid and a method for producing glutamic acid using the same, and more specifically, as a mutant of Brevibacterium lactofermentum ATCC 13869, it is possible to magnetize glutamic acid as a carbon source and a nitrogen source while having osmotic resistance. The present invention relates to a microorganism capable of producing high yield and high concentration of glutamic acid even in a medium containing waste molasses.

종래 미생물을 이용하여 글루타민산을 생산하는 방법으로는 배지내의 비오틴 함량을 제한하는 방법과 비오틴이 과잉으로 존재하는 배지의 사용에 있어서는 페니실린계 항생제나 또는 계면활성제(양이온, 음이온, 비이온계 계면활성제)를 첨가하여 글루타민산을 생산하였다.Conventional methods for producing glutamic acid using microorganisms include limiting the amount of biotin in the medium and using penicillin antibiotics or surfactants (cationic, anionic, nonionic surfactants) in the use of medium containing excessive amounts of biotin. Was added to produce glutamic acid.

그러나, 이와같은 종래의 방법은 폐당밀을 발효원료로 사용할 경우에 폐당밀이 서당 또는 환원당 이외의 불순물을 다량 함유하고 있어 생산성에 영향을 미치는 문제점이 있음은 물론, 페니실린을 첨가 후 글루타민산이 배지내에 축적이 되면 균체 외부의 삼투압이 증가되므로해서 글루타민산 생산세포가 용이하게 손상을 입거나, 생존 또는 글루타민산의 생산에 관여하는 각종 효소들의 손상 및 활성이 저하되는 문제점이 있었다.However, such a conventional method has a problem that when molasses molasses is used as a fermentation material, waste molasses contains a large amount of impurities other than sucrose or reducing sugar, which affects productivity, and glutamic acid is added to the medium after the addition of penicillin. When accumulated, since the osmotic pressure outside the cells increases, glutamic acid producing cells are easily damaged, or there is a problem that the damage and activity of various enzymes involved in survival or production of glutamic acid are reduced.

따라서 본 발명자 등은 상기 지적된 문제점 등을 제거함은 물론, 어떠한 원료나 생산방법을 사용하더라도 항상 글루타민산을 고수율, 고농도로 생산할 수 있는 미생물을 변이처리 결과 획득하여 본 발명을 완성하였다.Therefore, the present inventors have completed the present invention by removing the above-mentioned problems and the like, as well as obtaining a microorganism capable of producing glutamic acid at a high yield and high concentration at all times using any raw material or production method.

본 발명의 미생물(KFCC 10659)은 브레비 박테리움 락토퍼멘텀 ATCC 13869를 친주로 하여 자외선 조사, N-메틸-N'-니트로-N-니트로소구아니딘(NTG) 등의 변이유발제로 통상적인 방법에 따라 처리한후, 염화나트륨이 1.6-2.0몰 농도로 함유되어 있는 염화나트륨 첨가 배지(포도당 20g/l, 인산제1칼륨 1g/l, 인산2칼륨 0.5g/l, 황산암모늄 0.5g/l, 요소 1.0g/l, 황산철 20mg/l, 황산마그네슘 0.5g/l, 황산망간 20mg/l, 티아민염산염 20㎍/l, 비오틴 20㎍/l, 당밀 5g/l, 염화나트륨 1.6-2.0몰, pH 7.0)에서 3-5일간 배양하였다. 이때 대부분의 균주들은 염화나트륨의 농도가 높아 생육할 수 없으며 삼투압 내성이 높은 균주는 생육이 가능하므로 염화나트륨의 몰 농도를 점차로 높여 2.0몰에서도 생육이 가능한 변이주를 얻고, 여기에서 얻는 변이주를 원심분리 한후 회수, 세정하고 염화나트륨이 1.6-2.0몰 농도로 함유되어 있는 한천배지(염화나트륨 첨가배지의 조성에 한천을 20g/l 첨가한 배지)에 도말하여 발생한 코로니를 순수 분리한후, 이를 다시 염화나트륨 첨가배지에서 확인하여 염화나트륨이 2.0몰 포함된 배지에서도 생육이 가능한 변이주를 얻었다. 이것을 다시 상술한 변이 유발제로 처리하여 한천배지의 조성중 염화나트륨을 제외시킨 배지에 도말하고 배양한 다음, 글루타민산배지(글루타민산 나트륨염 10g/l, 인산제1칼륨 1g/l, 인산제2칼륨0.5g/l, 황산철 20mg/l, 황산망간 20mg/l, 티아민염산염 200㎍/l, 비오틴 20㎍/l, 당밀 5g/l, pH 7.0)에서 복제하여 한천배지의 조성중 염화나트륨을 제외시킨 배지에서는 생육을 하지만 글루타민산 배지에서는 생육할 수 없는 변이주를 분리하여 획득하고 이를 1988.12. 6. 자로 한국 종균협회에 기탁하였다(KFCC 10659).The microorganism of the present invention (KFCC 10659) is a conventional method as a mutagenesis agent such as ultraviolet irradiation, N-methyl-N'-nitro-N-nitrosoguanidine (NTG) using the Brevi bacterium lactofermentum ATCC 13869 as a parent After treatment in accordance with the following procedure, sodium chloride addition medium containing sodium chloride at a concentration of 1.6-2.0 molar (20 g / l glucose, 1 g potassium phosphate 1 g / l, 0.5 g / l potassium diphosphate, 0.5 g / l ammonium sulfate) 1.0 g / l, iron sulfate 20 mg / l, magnesium sulfate 0.5 g / l, manganese sulfate 20 mg / l, thiamine hydrochloride 20 µg / l, biotin 20 µg / l, molasses 5 g / l, sodium chloride 1.6-2.0 mol, pH 7.0 ) For 3-5 days. At this time, most strains cannot grow due to high concentration of sodium chloride, and strains with high osmotic resistance can be grown, so that the molar concentration of sodium chloride is gradually increased to obtain mutant strains capable of growing at 2.0 moles, and recovered after centrifugation of the mutant strains obtained therefrom. After washing, smearing the resulting colonies on the agar medium containing a concentration of 1.6-2.0 moles of sodium chloride (a medium containing 20 g / l of agar in the sodium chloride addition medium). Thus, a mutant strain capable of growing in a medium containing 2.0 mol of sodium chloride was obtained. This was again treated with the above-mentioned mutagenic agent, plated and cultured in the medium without sodium chloride in the composition of the agar medium, and then cultured with glutamate medium (10 g / l sodium glutamate, 1 g / l potassium phosphate, 0.5 g / dipotassium phosphate). l, 20 mg / l iron sulfate, 20 mg / l manganese sulfate, 200 µg / l thiamine hydrochloride, 20 µg / l biotin, 5 g / l molasses, pH 7.0) However, in glutamic acid medium, mutant strains that cannot be grown are isolated and obtained. 6. It was deposited with the Korean spawn association (KFCC 10659).

본 발명 미생물의 특성은 다음의 표에 기재된 바와 같다.The characteristics of the microorganism of the present invention are as described in the following table.

[표 1] ; 염화나트륨 농도에 대한 내성비교TABLE 1; Comparison of Tolerance to Sodium Chloride Concentration

Figure kpo00001
Figure kpo00001

<주> 사용배지 ; 한천배지<Note> Medium used; Agar Badge

+ ; 생육, - ; 생육치 못함+; Growth,-; Lack of growth

[표 2] ; 글루타민산 배지에서의 생육도 비교TABLE 2; Comparison of Growth in Glutamic Acid Medium

Figure kpo00002
Figure kpo00002

<주> 사용배지 ; 글루타민산배지 조성중 한천을 제외한 배지<Note> Medium used; Medium excluding agar from glutamate media

배양방법 ; 용량 500ml의 배양용 삼각 플라스크에 사용배지 40ml를 넣고 살균, 냉각 후 균주를 식균하여 30℃에서 180rpm으로 72시간 진탕 배양.Culture method; 40 ml of the used medium was added to a 500 ml culture Erlenmeyer flask, sterilized and cooled, followed by inoculation of the strain, followed by incubation for 72 hours at 30 ° C. at 180 rpm.

다음의 실시예에서 본 발명을 좀더 구체적으로 설명한다.The present invention is explained in more detail in the following examples.

실시예 1Example 1

사용균주 ; 본 발명 미생물(KFCC 10659), ATCC 13869Used strain; Microorganism of the Invention (KFCC 10659), ATCC 13869

1차종배지 ; 폐당밀 0.5%, 포도당 2.0%, MgSO40.5g/l, 요소 0.1%, FeSO420mg/l, MnSO420mg/l, K2HPO40.5g/l, KH2PO41g/l, (NH4)2SO40.5% 티아민염산염 200㎍/l, 비오틴 20㎍/l, pH 7.0Primary species medium; Waste molasses 0.5%, glucose 2.0%, MgSO 4 0.5g / l, urea 0.1%, FeSO 4 20mg / l, MnSO 4 20mg / l, K 2 HPO 4 0.5g / l, KH 2 PO 4 1g / l, ( NH 4 ) 2 SO 4 0.5% thiamine hydrochloride 200 μg / l, biotin 20 μg / l, pH 7.0

2차종배지 ; 폐당밀(전화당으로) 2.0%, 글루코오스 1%, 콘스팁리커 3%,MgS O40.5g/l. 요소 0.2%, KH2PO41g/l, K2HPO40.5g/l, FeSO410mg/l, MnSO410mg/l, (NH4)2SO40.3%, 티아민염산염 200㎍/l, 비오틴 100㎍/l, 소포제 약간, pH7.0Secondary species medium; Lung molasses (as invert sugar) 2.0%, glucose 1%, corn steep liquor 3%, MgS 0 4 0.5 g / l. Urea 0.2%, KH 2 PO 4 1g / l, K 2 HPO 4 0.5g / l, FeSO 4 10mg / l, MnSO 4 10mg / l, (NH 4 ) 2 SO 4 0.3%, Thiamine hydrochloride 200μg / l, Biotin 100 μg / l, Antifoam slightly, pH7.0

발효배지 ; 폐당밀(전화당으로) 8%, NH4H2PO40.15%, FeSO410mg/l, MnSO410㎎/l, 콘스팁리커 3%, (NH4)2SO40.3%, 티아민염산염 200㎍/l, 소포제 약간, pH 7.0Fermentation medium; Waste molasses (as invert sugar) 8%, NH 4 H 2 PO 4 0.15%, FeSO 4 10 mg / l, MnSO 4 10 mg / l, corn steep liquor 3%, (NH 4 ) 2 SO 4 0.3%, thiamine hydrochloride 200 μg / l, antifoam slightly, pH 7.0

1차종배양 ; 1차종배지를 40ml씩 250ml 용량의 진탕용 삼각 플라스크에 넣고 살균 후 균주를 식균하여 30℃에서 180rpm으로 20-24시간 진탕 배양하였다.Primary species culture; The primary seed medium was put into a 250 ml shake Erlenmeyer flask with 40 ml each, and after sterilization, the strains were inoculated and incubated at 30 ° C. at 180 rpm for 20-24 hours.

2차종배양 ; 2차 종배지를 2.6리터 용량의 시험용 발효조에 각 1.2리터씩 분주하고 121℃에서 10분간 살균 냉각 후 1차종배양에서 얻은 배양완료액을 5ml씩 접종한 다음, 공기를 매분당 0.5-1.0리터 공급하면서 900rpm으로 30℃에서 12-15시간 배양하였다.Secondary species culture; Dispense the secondary seed medium into 1.2 liter each of the test fermenter with 2.6 liter capacity, inoculate 5 ml of the culture solution obtained in the primary seed culture after sterilization cooling at 121 ° C for 10 minutes, and supply 0.5-1.0 liter of air per minute. While incubated at 900rpm for 12-15 hours at 30 ℃.

발효방법 ; 상기 발효배지를 5리터 용량의 시험발효조에 1.8리터씩 분주하고 121℃에서 10분간 살균, 냉각하여 2차종배양액을 약 150ml씩 접종한 후 공기를 매분당 1-2.5리터씩 공급하면서 900rpm, 30-37℃에서 배양하되 대수증식기 초기부터 말기[OD5620.15-0.4(OD562×100)] 사이에 페니실린을 0.3-1.2μ/ml 첨가하였다. 배양중 잔존 당농도가 0.5-1.5%가 되면 살균된 폐당밀 또는 폐당밀과 원당을 일정비율 혼합한 혼합당을 수시로 공급하였다.Fermentation method; The fermentation broth was dispensed 1.8 liters each into a 5 liter test fermentation tank, sterilized and cooled at 121 ° C. for 10 minutes, inoculated with about 150 ml of secondary culture medium, and then supplied with 1-2.5 liters of air at 900rpm, 30- but it incubated at 37 ℃ logarithmic growth phase penicillin between the initial end from [OD 562 0.15-0.4 (OD 562 × 100)] was added 0.3-1.2μ / ml. When the residual sugar concentration in the culture reached 0.5-1.5%, sterilized waste molasses or mixed sugars containing a certain ratio of waste molasses and raw sugar were frequently supplied.

추가한 당밀 또는 혼합당과 초기의 발효배지에 첨가된 당의 합계가 발효액량대비 19%가 될 때까지 계속배양하였다. 배양중 pH는 암모니아수를 사용하여 7.8로 조절하였다.Culture was continued until the sum of added molasses or mixed sugar and sugar added to the initial fermentation broth was 19% of the fermentation broth. The pH of the culture was adjusted to 7.8 using ammonia water.

배양완료 후 글루타민산의 농도는 ATCC 13869가 98.0g/l, KFCC l0659가 143.5g/l이었다.After completion of the culture, the concentration of glutamic acid was 98.0 g / l for ATCC 13869 and 143.5 g / l for KFCC 0659.

실시예 2Example 2

사용균주, 1차 및 2차 종배양 배지조성과 배양방법은 실시예 1과 동일하게 행하였다.Strains used, primary and secondary seed culture medium composition and culture method were carried out in the same manner as in Example 1.

발효방법 ; 대수증식기 초기부터 말기사이에 비이온계 계면활성제인 트윈 40을 발효액량 대비 50㎍/㎖-100㎍/㎖되게 첨가한 것을 제외하고는 실시예 1과 동일하게 행한 결과, 배양완료 후 글루타민산의 농도는 ATCC 13869가 101.2g/l, KFCC 10659가 l39.7g/l이었다.Fermentation method; Concentration of glutamic acid after completion of culture was carried out in the same manner as in Example 1 except that Tween 40, a nonionic surfactant, was added 50 µg / ml-100 µg / ml compared to the amount of fermentation broth between the beginning and the end of the logarithmic growth stage. ATCC 13869 was 101.2 g / l and KFCC 10659 was 19.7 g / l.

상술한 바와같이 본 발명의 미생물은 통상 글루타민산의 발효시에 사용되는 원료 즉, 포도당, 전분가수분해물(옥수수, 고구마, 타피호카 등의 전분), 폐당밀 등을 사용할 수 있고, 특히 폐당밀을 사용시에는 상술한 바와 같이 강한 삼투압 내성을 가지므로 발효중 글루타민산의 축적 농도를 높일 수 있을 뿐만 아니라, 글루타메이트 디하이드로게네이즈 역반응 기작의 효소 활성이 실활 또는 약화되어 있어 발효중 생산된 글루타민산의 소모를 방지하므로써 생산농도 및 생산수율을 향상시킬 수 있음이 확인되었다.As described above, the microorganism of the present invention can use raw materials commonly used in fermentation of glutamic acid, that is, glucose, starch hydrolyzate (starch of corn, sweet potato, tapioca, etc.), waste molasses, and the like, especially when waste molasses is used. As described above, since it has a strong osmotic resistance, not only can the concentration of glutamic acid be increased during fermentation, but also the enzyme activity of the glutamate dehydrogenase reverse reaction mechanism is inactivated or weakened, thereby preventing the consumption of glutamic acid produced during fermentation. It was confirmed that the production concentration and yield can be improved.

Claims (2)

삼투압 내성을 가짐과 동시에 글루타민산을 탄소원 및 질소원으로 자화할 수 없는 미생물로, 글루타민산을 생산하는 브레비박테리움 락토퍼덴텀 KFCC 10659.Brevibacterium lactoferdentum, which is a microorganism that is resistant to osmotic pressure and cannot magnetize glutamic acid to carbon and nitrogen sources, and produces glutamic acid KFCC 10659. 브레비박테리움 락토퍼덴텀 KFCC 10659를 폐당밀, 포도당, 전분가수분해물 및 원당 등이 포함된 배지중에서 배양하여 배양물로 부터 글루타민산을 채취하는 것을 특징으로 하는 미생물을 이용한 글루타민산의 제조방법.A method for producing glutamic acid using microorganisms, comprising culturing Brevibacterium lactoferdentum KFCC 10659 in a medium containing waste molasses, glucose, starch hydrolyzate, and raw sugar.
KR1019880016541A 1988-12-12 1988-12-12 Novel microorganism for producing of glutamic acid KR900007946B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019880016541A KR900007946B1 (en) 1988-12-12 1988-12-12 Novel microorganism for producing of glutamic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019880016541A KR900007946B1 (en) 1988-12-12 1988-12-12 Novel microorganism for producing of glutamic acid

Publications (2)

Publication Number Publication Date
KR900009964A KR900009964A (en) 1990-07-06
KR900007946B1 true KR900007946B1 (en) 1990-10-23

Family

ID=19280077

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880016541A KR900007946B1 (en) 1988-12-12 1988-12-12 Novel microorganism for producing of glutamic acid

Country Status (1)

Country Link
KR (1) KR900007946B1 (en)

Also Published As

Publication number Publication date
KR900009964A (en) 1990-07-06

Similar Documents

Publication Publication Date Title
US3849251A (en) Process for producing l-tryptophan
US3729381A (en) Process for producing l-methionine
KR100292299B1 (en) Microorganism producing glutamic acid and process for preparation glutamic acid using the same
US3809611A (en) Process for producing citric acid
US3763008A (en) Process for producing ribosides of heterocyclic organic bases by fermentation
KR900007948B1 (en) Novel microorganism for producing of glutamic acid
KR900007946B1 (en) Novel microorganism for producing of glutamic acid
KR100402320B1 (en) A microorganism Corynebacterium ammoniagenes NV4-82-9 being capable of producing 5&#39;-xanthylic acid in higher yield and a producing method of 5&#39;-xanthylic acid by using the same
EP0386476B1 (en) Process for producing L-alanine
KR900007947B1 (en) Novel microorganism for producing of glutamic acid
US4000040A (en) Method for producing L-aspartic acid by fermentation
KR100264740B1 (en) A microorganism producing glutamic acid and a producing method of the glutamic acid using the same
US3939042A (en) Process for the production of L-glutamic acid
KR900007938B1 (en) Novel microorganism for producing of glutamic acid
KR900007940B1 (en) Novel microorganism for producing of glutamic acid
KR900007939B1 (en) Novel microorganism for producing of glutamic acid
KR20010089980A (en) 5&#39;-Xanthylic acid producing microorganism
KR900007945B1 (en) Novel microorganism for producing of glutamic acid
KR100317901B1 (en) A microorganism producing glutamic acid and a method for producing glutamic acid using said microorganism
KR100317902B1 (en) A microorganism producing glutamic acid and a method for producing glutamic acid using said microorganism
EP0469517A2 (en) Process for producing L-glutamic acid
KR900007942B1 (en) Novel microorganism for producing of glutamin acid
KR900007944B1 (en) Novel microorganism for producing of glutamic acid
KR900007941B1 (en) Novel microorganism for producing of glutamic acid
KR100264741B1 (en) A microorganism producing glutamic acid and a producing method of the glutamic acid using the same

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20010917

Year of fee payment: 12

LAPS Lapse due to unpaid annual fee